These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5030811)

  • 41. Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer.
    Wampler GL; Mellette SJ; Kuperminc M; Regelson W
    Cancer Chemother Rep; 1972 Aug; 56(4):505-14. PubMed ID: 5081594
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
    Wiltshaw E; Kroner T
    Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of dibromodulcitol (NSC-104800).
    Andrews NC; Weiss AJ; Wilson W; Nealon T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):653-60. PubMed ID: 4426045
    [No Abstract]   [Full Text] [Related]  

  • 44. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD; Hurwitz BS
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract]   [Full Text] [Related]  

  • 45. Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
    Einzig A; Kelsen DP; Cheng E; Sordillo P; Heelan R; Winn R; Magill G
    Cancer Treat Rep; 1985 Dec; 69(12):1453-4. PubMed ID: 3907826
    [No Abstract]   [Full Text] [Related]  

  • 46. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
    [No Abstract]   [Full Text] [Related]  

  • 47. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
    Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
    Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934).
    Piccart M; Rozencweig M; Dodion P; Cumps E; Crespeigne N; Makaroff O; Atassi G; Kisner D; Kenis Y
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1263-6. PubMed ID: 7200026
    [No Abstract]   [Full Text] [Related]  

  • 49. [Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
    Tokunaga A; Onda M; Mizutani T; Miyamoto M; Nomura T; Hayashi H; Kiyama T; Umehara M; Nishi K; Andoh T
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3713-8. PubMed ID: 2596854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hexamethylmelamine (NSC-13875) for acute leukemia and solid tumors in children.
    Dyment PG; Fernbach DJ; Sutow WW
    J Clin Pharmacol New Drugs; 1973; 13(2):111-3. PubMed ID: 4568295
    [No Abstract]   [Full Text] [Related]  

  • 51. [Gastrointestinal complication of cancer chemotherapy].
    Tonoike Y; Hamaguchi T
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():153-8. PubMed ID: 23156501
    [No Abstract]   [Full Text] [Related]  

  • 52. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
    Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
    Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
    [No Abstract]   [Full Text] [Related]  

  • 54. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 55. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
    Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
    Moertel CG; Reitemeier RJ; Hahn RG
    Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
    Luce JK; Thurman WG; Isaacs BL; Talley RW
    Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
    [No Abstract]   [Full Text] [Related]  

  • 58. A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinoma.
    Rubin J; van Hazel GA; Schutt AJ; Moertel CG; O'Connell MJ
    Am J Clin Oncol; 1982 Oct; 5(5):539-40. PubMed ID: 7180832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vinblastine (NSC-49842) plus vincristine (NSC-67574) given in intensive 3-day courses as therapy for lymphomas, sarcomas, and other neoplasms.
    Stolinsky DC; Bogdon DL; Pugh RP; Braunwald J; Hestorff R; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):481-4. PubMed ID: 4586955
    [No Abstract]   [Full Text] [Related]  

  • 60. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.